Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer

BACKGROUND: The recently developed reagent, eribulin mesylate (eribulin), is a microtubule dynamics inhibitor with a mechanism of action that differs from those of taxanes and vinca alkaloids. This drug is considered to be a promising chemotherapeutic agent for the treatment of locally advanced or m...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashiwagi, Shinichiro, Fukushima, Wakaba, Asano, Yuka, Goto, Wataru, Takada, Koji, Noda, Satoru, Takashima, Tsutomu, Onoda, Naoyoshi, Ohsawa, Masahiko, Hirakawa, Kosei, Ohira, Masaichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580315/
https://www.ncbi.nlm.nih.gov/pubmed/28859615
http://dx.doi.org/10.1186/s12885-017-3598-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5580315/
https://www.ncbi.nlm.nih.gov/pubmed/28859615
http://dx.doi.org/10.1186/s12885-017-3598-5

Ejemplares similares